Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. Hexima Limited
  6. Company
    HXL   AU0000111932

HEXIMA LIMITED

(HXL)
SummaryChartsNewsCalendarCompanyFinancials 
Business Summary
Hexima Limited is an Australia-based clinical stage biotechnology company. The Company is engaged in the research and development of defensin peptides for applications as human therapeutics. The Company’s lead product candidate, pezadeftide applied in a topical formulation, is a potential new prescription treatment for toenail fungal infections or onychomycosis. pezadeftide is under Australian Phase IIb clinical trial. It develops for the treatment of onychomycosis. The Company holds granted, long-life patents protecting pezadeftide in markets globally..
Managers
Name Title Age Since
Michael Douglas Arthur Aldridge CEO, Non-Independent Non-Executive Director & MD 53 2020
Marilyn Ann Anderson, Dr. Executive Director & Chief Scientific Officer - 2010
Yolanda Gaspar, Dr. Head-Clinical Operations - -
Nicole Louise van der Weerden, Dr. Chief Operating Officer & Executive Director - 2020
Scott Robertson Independent Non-Executive Director - 2018
Leanne Ralph Secretary - 2021
Susanna Herd, Dr. Manager-Intellectual Property - -
Peter J. Welburn, Dr. Chief Development Officer - 2020
Helen Molloy Financial Controller - 2021
Members of the board
Name Title Age Since
Jonathan West, Dr. Non-Executive Chairman - 2014
Marilyn Ann Anderson, Dr. Executive Director & Chief Scientific Officer - 2010
Nicole Louise van der Weerden, Dr. Chief Operating Officer & Executive Director - 2020
Justin Zhen Nan Yap Non-Executive Director - 2018
Scott Robertson Independent Non-Executive Director - 2018
Michael Douglas Arthur Aldridge CEO, Non-Independent Non-Executive Director & MD 53 2020
Jake R. Nunn Non-Executive Director 49 2021
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 130,857,724 50,124,460 38.3% 0 0.0% 38.3%
Company contact information
Hexima Ltd.
La Trobe Institute for Molecular Sci
La Trobe University
Level 4, LIMS2
Melbourne, Victoria (VIC) 3086

Phone : +61.3.9479.1210
Fax : +61.3.9479.1266
Web : http://www.hexima.com.au
Brand Portfolio
In partnership withAllbrands.markets
More brands of Hexima Limited